文献速递血脂与心血管预防冠心病

免疫检查点治疗与动脉粥样硬化:机制与临床意义

Immune Checkpoint Therapies and Atherosclerosis: Mechanisms and Clinical Implications: JACC State-of-the-Art Review.
PubMed 文献 · J Am Coll Cardiol · 2022-01-01

本文综述了免疫检查点治疗对动脉粥样硬化的潜在影响。T细胞免疫在动脉粥样硬化形成中起关键作用,已批准和研究中的免疫检查点治疗可能促进动脉粥样硬化的发展与加重。文章还探讨了胆固醇代谢在肿瘤发生中的作用,以及对接受免疫检查点治疗的肿瘤患者进行动脉粥样硬化性心血管疾病监测的意义。

要点

  • 免疫检查点治疗除心肌炎外,还可能影响动脉粥样硬化。
  • T细胞免疫在动脉粥样硬化形成中发挥关键作用。
  • 肿瘤患者接受免疫检查点治疗时需关注动脉粥样硬化性心血管疾病。

核心结论

  • 免疫检查点治疗可能促进动脉粥样硬化的发展和加重。

研究设计与样本

  • 本文为JACC最先进综述,总结了T细胞免疫在动脉粥样硬化中的作用及免疫检查点治疗对动脉粥样硬化的分子效应和临床关联。

主要发现

  • 临床前研究已明确炎症和适应性免疫在动脉粥样硬化中的关键作用。
  • 一些新兴临床研究提示免疫检查点靶向治疗可能在动脉粥样硬化的发生和加重中起作用。
  • 已有报告详细描述了免疫检查点治疗可能引起的多种不良炎症反应,但 largely 限于心肌炎。

临床怎么用

  • 在接受免疫检查点治疗的肿瘤患者中,应考虑动脉粥样硬化性心血管疾病的监测和管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Immune checkpoint inhibitor therapy has revolutionized the treatment of advanced malignancies in recent years. Numerous reports have detailed the myriad of possible adverse inflammatory effects of immune checkpoint therapies, including within the cardiovascular system. However, these reports have been largely limited to myocarditis. The critical role of inflammation and adaptive immunity in atherosclerosis has been well characterized in preclinical studies, and several emerging clinical studies indicate a potential role of immune checkpoint targeting therapies in the development and exacerbation of atherosclerosis. In this review, we provide an overview of the role of T-cell immunity in atherogenesis and describe the molecular effects and clinical associations of both approved and investigational immune checkpoint therapy on atherosclerosis. We also highlight the role of cholesterol metabolism in oncogenesis and discuss the implications of these associations on future treatment and monitoring of atherosclerotic cardiovascular disease in the oncologic population receiving immune checkpoint therapy.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Vuong JT, Stein-Merlob AF, Nayeri A, et al. Immune Checkpoint Therapies and Atherosclerosis: Mechanisms and Clinical Implications: JACC State-of-the-Art Review. J Am Coll Cardiol. 2022. PMID: 35144750. doi:10.1016/j.jacc.2021.11.048

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。